Because oncogenic NRAS also drives ERK signalling in cancer, we tested the effect of NRAS knockdown in HT-1080 and RD soft tissue sarcoma cell lines (which both contain a Q61 NRAS mutation) and found that NRAS knockdown sensitised cells to ER-stress. Here, NRAS is linked to soft tissue sarcoma.